Spine Surgery Biologics Market, Global Outlook and Forecast 2024-2030
The global Spine Surgery Biologics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Bone Graft Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Spine Surgery Biologics include Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine and K2M, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products.
This report aims to provide a comprehensive presentation of the global market for Spine Surgery Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spine Surgery Biologics. This report contains market size and forecasts of Spine Surgery Biologics in global, including the following market information:
Global Spine Surgery Biologics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Spine Surgery Biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Spine Surgery Biologics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Spine Surgery Biologics Market Segment Percentages, by Type, 2023 (%)
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Global Spine Surgery Biologics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Spine Surgery Biologics Market Segment Percentages, by Application, 2023 (%)
Open Surgery
Minimally Invasive Surgery
Global Spine Surgery Biologics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Spine Surgery Biologics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Spine Surgery Biologics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Spine Surgery Biologics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Outline of Major Chapters:
Chapter 1: Introduces the definition of Spine Surgery Biologics, market overview.
Chapter 2: Global Spine Surgery Biologics market size in revenue.
Chapter 3: Detailed analysis of Spine Surgery Biologics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Spine Surgery Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
